Target intelligence / Profile preview

DNA Gyrase Subunit B (GyrB)

Target
GyrB
Molecular classification
Enzyme, Topoisomerase, Type II Topoisomerase, ATPase
01

Overview

DNA gyrase subunit B (GyrB) is one of the two essential subunits that make up bacterial DNA gyrase, a type II topoisomerase unique to prokaryotes. The enzyme is a heterotetramer composed of two GyrA and two GyrB subunits. DNA gyrase introduces negative supercoils into closed circular double-stranded DNA in an ATP-dependent manner, which is crucial for maintaining the underwound state of bacterial chromosomes and facilitating processes such as replication, transcription, recombination, and repair. GyrB is absent in mammals, making it an attractive target for antibacterial drug development due to its essential role in bacterial viability without off-target effects on human cells. Several antibiotics target either the A or B subunit; novobiocin specifically inhibits the ATP-binding site on GyrB. Recent studies have identified novel small-molecule inhibitors targeting this domain using structure-based virtual screening approaches—these compounds show promising activity against bacterial strains resistant to existing drugs like ciprofloxacin or novobiocin.

02

Mechanism of action

Inhibition of ATP binding and hydrolysis; stabilization of specific residues in its active site

03

Biological functions

DNA supercoilingDNA decatenationDNA replicationDNA transcriptionDNA repairChromosome maintenance
04

Disease associations

InfectionBacterial infection
05

Safety considerations

Potential for development of bacterial resistanceOff-target effects on bacterial microbiomeLimited efficacy against certain bacterial strains
06

Interacting drugs

Novobiocin

2 more in the full profile.

Beyond the preview

Go deeper on DNA Gyrase Subunit B (GyrB).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA Gyrase Subunit B (GyrB).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call